RecruitingNot applicableNCT06582199

Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD

Studying Early-onset autosomal dominant Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Emmanuel GOGNAT, MD, PhD
Assistance Publique - Hôpitaux de Paris
Intervention
Blood sample(other)
Enrollment
244 target
Eligibility
50-90 years · All sexes
Timeline
20242027

Study locations (1)

Collaborators

National Research Agency, France · Institut National de la Santé Et de la Recherche Médicale, France · Centre National de la Recherche Scientifique, France · URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06582199 on ClinicalTrials.gov

Other trials for Early-onset autosomal dominant Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for Early-onset autosomal dominant Alzheimer disease

← Back to all trials